{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:52:39Z","timestamp":1793170359494,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["MSH-141971"],"award-info":[{"award-number":["MSH-141971"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","award":["287PHY"],"award-info":[{"award-number":["287PHY"]}],"id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Most individuals chronically infected with hepatitis C virus (HCV) are asymptomatic during the initial stages of infection and therefore the precise timing of infection is often unknown. Retrospective estimation of infection duration would improve existing surveillance data and help guide treatment. While intra-host viral diversity quantifications such as Shannon entropy have previously been utilized for estimating duration of infection, these studies characterize the viral population from only a relatively short segment of the HCV genome. In this study intra-host diversities were examined across the HCV genome in order to identify the region most reflective of time and the degree to which these estimates are influenced by high-risk activities including those associated with HCV acquisition. Shannon diversities were calculated for all regions of HCV from 78 longitudinally sampled individuals with known seroconversion timeframes. While the region of the HCV genome most accurately reflecting time resided within the NS3 gene, the gene region with the highest capacity to differentiate acute from chronic infections was identified within the NS5b region. Multivariate models predicting duration of infection from viral diversity significantly improved upon incorporation of variables associated with recent public, unsupervised drug use. These results could assist the development of strategic population treatment guidelines for high-risk individuals infected with HCV and offer insights into variables associated with a likelihood of transmission.<\/jats:p>","DOI":"10.1038\/s41598-021-88132-8","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T10:09:20Z","timestamp":1620727760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs"],"prefix":"10.1038","volume":"11","author":[{"given":"Vincent","family":"Montoya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita Y. M.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan Y.","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanson J.","family":"Brumme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea D.","family":"Olmstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanna","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Richard Harrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Joy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"88132_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2017.03.013","volume":"169","author":"A Stern","year":"2017","unstructured":"Stern, A. et al. The evolutionary pathway to virulence of an RNA virus. Cell 169, 35-46.e19 (2017).","journal-title":"Cell"},{"key":"88132_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-00354-5","volume":"8","author":"Y Xiao","year":"2017","unstructured":"Xiao, Y. et al. Poliovirus intrahost evolution is required to overcome tissue-specific innate immune responses. Nat. Commun. 8, 1\u201312 (2017).","journal-title":"Nat. Commun."},{"key":"88132_CR3","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.celrep.2014.07.011","volume":"8","author":"A Stern","year":"2014","unstructured":"Stern, A. et al. Costs and benefits of mutational robustness in RNA viruses. Cell Rep. 8, 1026\u20131036 (2014).","journal-title":"Cell Rep."},{"key":"88132_CR4","doi-asserted-by":"publisher","first-page":"e1004874","DOI":"10.1371\/journal.ppat.1004874","volume":"11","author":"ND Grubaugh","year":"2015","unstructured":"Grubaugh, N. D. et al. Experimental evolution of an RNA virus in wild birds: evidence for host-dependent impacts on population structure and competitive fitness. PLoS Pathog. 11, e1004874 (2015).","journal-title":"PLoS Pathog."},{"key":"88132_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","volume":"151","author":"J-M Pawlotsky","year":"2016","unstructured":"Pawlotsky, J.-M. Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens. Gastroenterology 151, 70\u201386 (2016).","journal-title":"Gastroenterology"},{"key":"88132_CR6","first-page":"vex041","volume":"4","author":"BR Jones","year":"2017","unstructured":"Jones, B. R., Howe, A. Y. M., Harrigan, P. R. & Joy, J. B. The global origins of resistance-associated variants in the non-structural proteins 5A and 5B of the hepatitis C virus. Virus Evol. 4, vex041 (2017).","journal-title":"Virus Evol."},{"issue":"9171","key":"88132_CR7","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/S0140-6736(98)12291-2","volume":"353","author":"J Durant","year":"1999","unstructured":"Durant, J. et al. Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial. Lancet 353(9171), 2195\u20132199 (1999).","journal-title":"Lancet"},{"key":"88132_CR8","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3851\/IMP2476","volume":"17","author":"Y Khudyakov","year":"2012","unstructured":"Khudyakov, Y. Molecular surveillance of hepatitis C. Antiviral Ther. 17, 1465\u20131470 (2012).","journal-title":"Antiviral Ther."},{"key":"88132_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1128\/MMBR.05023-11","volume":"76","author":"E Domingo","year":"2012","unstructured":"Domingo, E., Sheldon, J. & Perales, C. Viral quasispecies evolution. Microbiol. Mol. Biol. Rev. 76, 159\u2013216 (2012).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"88132_CR10","doi-asserted-by":"publisher","first-page":"831","DOI":"10.4254\/wjh.v7.i6.831","volume":"7","author":"N Echeverr\u00eda","year":"2015","unstructured":"Echeverr\u00eda, N., Moratorio, G., Cristina, J. & Moreno, P. Hepatitis C virus genetic variability and evolution. World J. Hepatol. 7, 831 (2015).","journal-title":"World J. Hepatol."},{"key":"88132_CR11","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.1128\/JVI.00201-09","volume":"83","author":"JM Cuevas","year":"2009","unstructured":"Cuevas, J. M., Gonzalez-Candelas, F., Moya, A. & Sanjuan, R. Effect of ribavirin on the mutation rate and spectrum of hepatitis C virus in vivo. J. Virol. 83, 5760\u20135764 (2009).","journal-title":"J. Virol."},{"key":"88132_CR12","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.1128\/JVI.02271-09","volume":"84","author":"GP Wang","year":"2010","unstructured":"Wang, G. P., Sherrill-Mix, S. A., Chang, K. M., Quince, C. & Bushman, F. D. Hepatitis C virus transmission bottlenecks analyzed by deep sequencing. J. Virol. 84, 6218\u20136228 (2010).","journal-title":"J. Virol."},{"key":"88132_CR13","doi-asserted-by":"publisher","first-page":"e1002243","DOI":"10.1371\/journal.ppat.1002243","volume":"7","author":"RA Bull","year":"2011","unstructured":"Bull, R. A. et al. Sequential bottlenecks drive viral evolution in early acute hepatitis c virus infection. PLoS Pathog. 7, e1002243 (2011).","journal-title":"PLoS Pathog."},{"key":"88132_CR14","doi-asserted-by":"publisher","first-page":"6369","DOI":"10.1128\/JVI.02204-10","volume":"85","author":"S Ramachandran","year":"2011","unstructured":"Ramachandran, S. et al. Temporal variations in the hepatitis C virus intrahost population during chronic infection. J. Virol. 85, 6369\u20136380 (2011).","journal-title":"J. Virol."},{"key":"88132_CR15","doi-asserted-by":"publisher","first-page":"e19562","DOI":"10.1371\/journal.pone.0019562","volume":"6","author":"H Li","year":"2011","unstructured":"Li, H. et al. Genetic diversity of near genome-wide hepatitis C virus sequences during chronic infection: evidence for protein structural conservation over time. PLoS ONE 6, e19562 (2011).","journal-title":"PLoS ONE"},{"key":"88132_CR16","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1128\/jvi.68.3.1494-1500.1994","volume":"68","author":"YK Shimizu","year":"1994","unstructured":"Shimizu, Y. K. et al. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 68, 1494\u20131500 (1994).","journal-title":"J. Virol."},{"key":"88132_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/hep.510250233","volume":"25","author":"SL Tsai","year":"1997","unstructured":"Tsai, S. L., Liaw, Y. F., Chen, M. H., Huang, C. Y. & Kuo, G. C. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25, 449\u2013458 (1997).","journal-title":"Hepatology"},{"key":"88132_CR18","first-page":"163","volume":"11","author":"IV Astrakhantseva","year":"2012","unstructured":"Astrakhantseva, I. V. et al. Differences in variability of hypervariable region 1 of hepatitis C virus (HCV) between acute and chronic stages of HCV infection. In Silico Biol. 11, 163\u2013173 (2012).","journal-title":"In Silico Biol."},{"key":"88132_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.meegid.2015.04.017","volume":"33","author":"AD Olmstead","year":"2015","unstructured":"Olmstead, A. D. et al. A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission events. Infect. Genet. Evol. 33, 101\u2013109 (2015).","journal-title":"Infect. Genet. Evol."},{"key":"88132_CR20","doi-asserted-by":"publisher","first-page":"veaa103","DOI":"10.1093\/ve\/veaa103","volume":"7","author":"PB Icer Baykal","year":"2021","unstructured":"Icer Baykal, P. B., Lara, J., Khudyakov, Y., Zelikovsky, A. & Skums, P. Quantitative differences between intra-host HCV populations from persons with recently established and persistent infections. Virus Evol. 7, veaa103 (2021).","journal-title":"Virus Evol."},{"key":"88132_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12864-017-4269-2","volume":"18","author":"J Lara","year":"2017","unstructured":"Lara, J., Teka, M. & Khudyakov, Y. Identification of recent cases of hepatitis C virus infection using physical-chemical properties of hypervariable region 1 and a radial basis function neural network classifier. BMC Genomics 18, 33\u201342 (2017).","journal-title":"BMC Genomics"},{"key":"88132_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.meegid.2019.02.032","volume":"71","author":"A Abayasingam","year":"2019","unstructured":"Abayasingam, A. et al. Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing. Infect. Genet. Evol. 71, 36\u201341 (2019).","journal-title":"Infect. Genet. Evol."},{"key":"88132_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/jvh.12616","volume":"24","author":"C Rodrigo","year":"2017","unstructured":"Rodrigo, C. et al. Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC 3 Study. J. Viral Hepat. 24, 43\u201352 (2017).","journal-title":"J. Viral Hepat."},{"key":"88132_CR24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/jvh.13051","volume":"26","author":"C Rodrigo","year":"2019","unstructured":"Rodrigo, C. et al. Genomic variability of within-host hepatitis C variants in acute infection. J. Viral Hepat. 26, 476\u2013484 (2019).","journal-title":"J. Viral Hepat."},{"key":"88132_CR25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/hep.26623","volume":"59","author":"M Hellard","year":"2014","unstructured":"Hellard, M., Doyle, J. S., Sacks-Davis, R., Thompson, A. J. & McBryde, E. Eradication of hepatitis C infection: the importance of targeting people who inject drugs. Hepatology 59, 366\u2013369 (2014).","journal-title":"Hepatology"},{"key":"88132_CR26","unstructured":"BC Centre for excellence. BCCSU Vidus study description. Available from: https:\/\/www.bccsu.ca\/vidus\/"},{"key":"88132_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11524-012-9771-x","volume":"90","author":"IA Linden","year":"2013","unstructured":"Linden, I. A., Mar, M. Y., Werker, G. R., Jang, K. & Krausz, M. Research on a vulnerable neighborhood\u2014the Vancouver downtown eastside from 2001 to 2011. J. Urban Health 90, 559\u2013573 (2013).","journal-title":"J. Urban Health"},{"key":"88132_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-10-53","volume":"10","author":"EZ Zhang","year":"2013","unstructured":"Zhang, E. Z. et al. Development of a sensitive RT-PCR method for amplifying and sequencing near full-length HCV genotype 1 RNA from patient samples. Virol. J. 10, 1\u20136 (2013).","journal-title":"Virol. J."},{"key":"88132_CR29","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1128\/JCM.00650-15","volume":"53","author":"CKS Chui","year":"2015","unstructured":"Chui, C. K. S. et al. Development and validation of two screening assays for the hepatitis C virus NS3 Q80K polymorphism associated with reduced response to combination treatment regimens containing simeprevir. J. Clin. Microbiol. 53, 2942\u20132950 (2015).","journal-title":"J. Clin. Microbiol."},{"key":"88132_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"ER Lee","year":"2020","unstructured":"Lee, E. R. et al. Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing. Sci. Rep. 10, 1\u201310 (2020).","journal-title":"Sci. Rep."},{"key":"88132_CR31","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2018","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2018)."},{"key":"88132_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-21706-2","volume-title":"Modern Applied Statistics with S","author":"WN Venables","year":"2002","unstructured":"Venables, W. N. & Ripley, B. D. Modern Applied Statistics with S 4th edn. (Springer, 2002).","edition":"4"},{"key":"88132_CR33","doi-asserted-by":"publisher","unstructured":"Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12(1). https:\/\/doi.org\/10.1186\/1471-2105-12-77 (2011).","DOI":"10.1186\/1471-2105-12-77"},{"key":"88132_CR34","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772\u2013780 (2013).","journal-title":"Mol. Biol. Evol."},{"key":"88132_CR35","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1093\/bioinformatics\/btu531","volume":"30","author":"A Laarson","year":"2014","unstructured":"Laarson, A. AliView: a fast and lightweight alignment viewer and editor for large data sets. Bioinformatics 30, 3276\u20133278 (2014).","journal-title":"Bioinformatics"},{"key":"88132_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/2041-210X.12628","volume":"8","author":"G Yu","year":"2017","unstructured":"Yu, G., Smith, D. K., Zhu, H., Guan, Y. & Lam, T. T. Y. ggtree: an r package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol. Evol. 8, 28\u201336 (2017).","journal-title":"Methods Ecol. Evol."},{"key":"88132_CR37","doi-asserted-by":"publisher","first-page":"e9490","DOI":"10.1371\/journal.pone.0009490","volume":"5","author":"MN Price","year":"2010","unstructured":"Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2\u2014approximately maximum-likelihood trees for large alignments. PLoS ONE 5, e9490 (2010).","journal-title":"PLoS ONE"},{"key":"88132_CR38","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.3390\/v7122968","volume":"7","author":"A Ahmed","year":"2015","unstructured":"Ahmed, A. & Felmlee, D. J. Mechanisms of hepatitis C viral resistance to direct acting antivirals. Viruses 7, 6716\u20136729 (2015).","journal-title":"Viruses"},{"key":"88132_CR39","doi-asserted-by":"publisher","first-page":"e38028","DOI":"10.1371\/journal.pone.0038028","volume":"7","author":"Y Kim","year":"2012","unstructured":"Kim, Y. et al. A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV). PLoS ONE 7, e38028 (2012).","journal-title":"PLoS ONE"},{"key":"88132_CR40","first-page":"1745","volume":"119","author":"B Rehermann","year":"2009","unstructured":"Rehermann, B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J. Clin. 119, 1745\u20131754 (2009).","journal-title":"J. Clin."},{"key":"88132_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1084\/jem.20100388","volume":"209","author":"J Schulze zur Wiesch","year":"2012","unstructured":"Schulze zur Wiesch, J. et al. Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. J. Exp. Med. 209, 61\u201375 (2012).","journal-title":"J. Exp. Med."},{"key":"88132_CR42","first-page":"486","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. 15, 486\u2013499 (2015).","journal-title":"Nat. Rev."},{"key":"88132_CR43","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","volume":"30","author":"GD Victora","year":"2012","unstructured":"Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu. Rev. Immunol. 30, 429\u2013457 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"88132_CR44","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3389\/fimmu.2017.01057","volume":"8","author":"M Soldemo","year":"2017","unstructured":"Soldemo, M. & Karlsson Hedestam, G. B. Env-specific antibodies in chronic infection versus in vaccination. Front. Immunol. 8, 1057 (2017).","journal-title":"Front. Immunol."},{"key":"88132_CR45","doi-asserted-by":"publisher","first-page":"22725","DOI":"10.1074\/jbc.R110.125294","volume":"30","author":"KD Raney","year":"2010","unstructured":"Raney, K. D., Sharma, S. D., Moustafa, I. M. & Cameron, C. E. Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target. J. Biol. Chem. 30, 22725\u201322731 (2010).","journal-title":"J. Biol. Chem."},{"key":"88132_CR46","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/eji.200636783","volume":"37","author":"FA Castelli","year":"2007","unstructured":"Castelli, F. A. et al. Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and core proteins. Eur. J. Immunol. 37, 1513\u20131523 (2007).","journal-title":"Eur. J. Immunol."},{"key":"88132_CR47","doi-asserted-by":"publisher","first-page":"13034","DOI":"10.1073\/pnas.96.23.13034","volume":"96","author":"S Bressanelli","year":"1999","unstructured":"Bressanelli, S. et al. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 96, 13034\u201313039 (1999).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"88132_CR48","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.4049\/jimmunol.175.6.3603","volume":"175","author":"J Schulze zur Wiesch","year":"2005","unstructured":"Schulze zur Wiesch, J. et al. Broad Repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J. Immunol. 175, 3603\u20133613 (2005).","journal-title":"J. Immunol."},{"key":"88132_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/hep.27375","volume":"61","author":"EF Donaldson","year":"2015","unstructured":"Donaldson, E. F., Harrington, P. R., Orear, J. J. & Naeger, L. K. Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir. Hepatology 61, 56\u201365 (2015).","journal-title":"Hepatology"},{"key":"88132_CR50","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/hep.27734","volume":"61","author":"V Montoya","year":"2015","unstructured":"Montoya, V. et al. Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: a population-level tool for incidence estimation. Hepatology 61, 1842\u20131850 (2015).","journal-title":"Hepatology"},{"key":"88132_CR51","unstructured":"Torres, A. A. et al. Characterization of acute HCV infection and transmission clusters in people who currently inject drugs in Catalonia: usefulness of dried blood spots. Hepatology (2021)."},{"key":"88132_CR52","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1128\/JVI.00077-10","volume":"84","author":"KJ Bar","year":"2010","unstructured":"Bar, K. J. et al. Wide variation in the multiplicity of HIV-1 infection among injection drug users. J. Virol. 84, 6241\u20136247 (2010).","journal-title":"J. Virol."},{"key":"88132_CR53","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/01.mjt.0000132250.95650.85","volume":"11","author":"R Vallejo","year":"2004","unstructured":"Vallejo, R., de Leon-Casasola, O. & Benyamin, R. Opioid therapy and immunosuppression: a review. Am. J. Ther. 11, 464\u2013475 (2004).","journal-title":"Am. J. Ther."},{"key":"88132_CR54","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.drugalcdep.2013.03.024","volume":"132","author":"D Werb","year":"2013","unstructured":"Werb, D. et al. Patterns of injection drug use cessation during an expansion of syringe exchange services in a Canadian setting. Drug Alcohol Depend. 132, 535\u2013540 (2013).","journal-title":"Drug Alcohol Depend."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88132-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88132-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88132-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T10:15:03Z","timestamp":1675246503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88132-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88132"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88132-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,11]]},"assertion":[{"value":"9 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9986"}}